Stocks and Investing
Stocks and Investing
Fri, November 8, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yatin Suneja Downgraded (ANAB) to Hold on, Nov 8th, 2019
Yatin Suneja of Guggenheim, Downgraded "AnaptysBio, Inc." (ANAB) to Hold on, Nov 8th, 2019.
Yatin has made no other calls on ANAB in the last 4 months.
There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, all agree with Yatin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Alethia Young of "Credit Suisse" Maintained at Hold with Decreased Target to $48 on, Thursday, October 3rd, 2019
- M. Auster of "Credit Suisse" Maintained at Hold with Decreased Target to $75 on, Friday, August 9th, 2019
Contributing Sources